EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Effect of Dermal Fibroblast‐Conditioned Media on Human Dermal Fibroblasts Treated With Electromagnetic Transduction Therapy

Jeongah Ko, Sang Bum Suh, Yeong Ju Oh, Ji Youn Suh, Sung Bin Cho

Skin Research and Technology · 2026

DOI: 10.1111/srt.70394 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Skin Research and Technology, 2026. Verfasst von Jeongah Ko und 4 weiteren Autor:innen. Beteiligte Einrichtung: Ko Jung A Clinic, Seoul, South Korea. Hauptthemen laut MEDLINE: Fibroblasts. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Electromagnetic transduction therapy (EMTT) is a high‐intensity pulsed electromagnetic field therapy used in musculoskeletal medicine. However, its therapeutic effects on human dermal fibroblasts (HDFs) remain unclear. Secretomes from human dermal fibroblast‐conditioned medium (HDFCM) can enhance wound repair and tissue regeneration.

Methods

Young and aged HDFs were treated with EMTT (40 or 80 mT) following HDFCM pretreatment (0, 30, or 60%). Proliferation and migration were assessed using cell proliferation and wound healing assays. Senescence‐associated β‐galactosidase (SA‐β‐Gal) staining and enzyme‐linked immunosorbent assay (ELISA) were performed to evaluate the effects of EMTT and HDFCM on senescence and pro‐ and anti‐inflammatory cytokine secretion.

Results

HDFCM significantly enhanced the proliferation of young and aged HDFs, particularly aged cells, in a dose‐dependent manner. EMTT at 40 mT further enhanced these effects, with 40 mT EMTT plus 30% HDFCM yielding the greatest increase in the number of aged HDF. SA‐β‐Gal activity, minimal in young cells, was elevated in aged HDFs, but was reduced by 40 mT EMTT with or without HDFCM. Contrastingly, 80 mT EMTT increased SA‐β‐Gal activity unless counteracted by 60% HDFCM. Moreover, interleukin‐6 was upregulated and transforming growth factor‐β was downregulated by HDFCM and EMTT treatments.

Conclusion

EMTT at low magnetic field strength, particularly if combined with HDFCM, promotes proliferation and migration while reducing senescence in aged HDFs. This approach may offer a promising therapeutic strategy for skin regeneration and antiaging applications, especially for aging or damaged dermal tissues.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibroblastsHumansCulture Media, ConditionedCell ProliferationCellular SenescenceCell MovementCells, CulturedDermisWound HealingElectromagnetic FieldsCytokines

Stichwörter der Autor:innen

cellular senescencedermal fibroblast‐conditioned mediaelectromagnetic transduction therapyhuman dermal fibroblastneocollagenesisneoelastogenesiswound healing

Substanzen

Culture Media, ConditionedCytokines

Autor:innen und Institutionen

  • Ko Jung A Clinic, Seoul, South Korea.
  • BNV Biolab, Seoul, South Korea.
  • Yonsei Seran Dermatology and Laser Clinic, Seoul, South Korea.

Zitieren

APA

Ko, J., Suh, S. B., Oh, Y. J., Suh, J. Y., & Cho, S. B. (2026). Effect of Dermal Fibroblast‐Conditioned Media on Human Dermal Fibroblasts Treated With Electromagnetic Transduction Therapy. Skin Research and Technology. https://doi.org/10.1111/srt.70394

Vancouver

Ko J, Suh SB, Oh YJ, Suh JY, Cho SB. Effect of Dermal Fibroblast‐Conditioned Media on Human Dermal Fibroblasts Treated With Electromagnetic Transduction Therapy. Skin Research and Technology. 2026. doi:10.1111/srt.70394

BibTeX
@article{Ko2026,
  author = {Ko, Jeongah and Suh, Sang Bum and Oh, Yeong Ju and Suh, Ji Youn and Cho, Sung Bin},
  title = {Effect of Dermal Fibroblast‐Conditioned Media on Human Dermal Fibroblasts Treated With Electromagnetic Transduction Therapy},
  journal = {Skin Research and Technology},
  year = {2026},
  doi = {10.1111/srt.70394}
}
Kostenlos starten →